Using the latest TTM figures, AMGEN shows a gross margin of 69.5%, an operating margin of 30%, an EBITDA margin of 46.3%, and a net margin of 23%. Operating margin had the largest improvement, increasing by 6.5 percentage points, while the other available margins also improved.
Over the last 3 years, AMGEN recorded average margins of 65.49% gross, 24.08% operating, 44.21% EBITDA, and 17.52% net. The current gross, operating, EBITDA, and net margins are all above their three-year averages.
All available margins expanded year over year, led by operating margin with an increase of 6.5 percentage points.
Across the last 3 years, AMGEN's gross margin came to 65.49%. The current gross margin stands at 69.5%, 4 percentage points above its three-year average. Gross margin was highest at 70% in Dec 2023 and lowest at 60.5% in Sep 2024.
Across the last 3 years, AMGEN's operating margin averaged 24.08%. Against its three-year average, AMGEN's operating margin is currently 30%, 5.9 percentage points above its three-year average. Operating margin was highest at 30% in Jun 2026 and lowest at 19.1% in Sep 2024.
Over the last 3 years, AMGEN had an average EBITDA margin of 44.21%. Against its three-year average, AMGEN's EBITDA margin is currently 46.3%, 2.1 percentage points above its three-year average. Looking back over the last 3 years, AMGEN's EBITDA margin reached 52.5% at its highest point in Dec 2023 and 38.2% at its lowest in Jun 2024.
Over the last 3 years, AMGEN's net margin averaged 17.52%. The current net margin of 23% is 5.5 percentage points above its three-year average. During this period, net margin reached a high of 23.8% in Dec 2023 and a low of 10.1% in Jun 2024.
With a gross margin of 69.5%, AMGN stands higher than the Healthcare sector and the industry average but lower than its peers average. But when looking at the Healthcare sector average of 68.4%, AMGEN's gross margin is only 1.6% higher.
For the period ending Jun 30, 2026, AMGN recorded a gross margin of 69.5%.
For the period ending Jun 30, 2026, AMGN recorded an operating margin of 30%.
The current EBITDA margin for AMGN is 46.3% as of Jun 30, 2026.
For the period ending Jun 30, 2026, AMGN recorded a net margin of 23%.
Over the last 3 years, AMGEN's margins averaged 65.5% gross, 24.1% operating, 44.2% EBITDA, and 17.5% net.
AMGEN's highest recorded margins during the past 5 years were 75.8% gross in Sep 2022, 36.6% operating in Sep 2022, 55.7% EBITDA in Jun 2023, and 30.2% net in Mar 2023.
Over this 5-year history, AMGEN's margins fell as low as 60.5% gross in Sep 2024, 19.1% operating in Sep 2024, 38.2% EBITDA in Jun 2024, and 10.1% net in Jun 2024.